Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Dec 5, 2012 (14 years ago)

PredniSONE Tablets

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Presence of Foreign Substance: A complaint was received for black specks identified as stainless steel inclusions and cellulose with trace amounts of aluminum and iron-rich inclusions.

Cause type: Particulate / foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.

What was recalled

PredniSONE Tablets, USP, 20 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1477-01), b) 500-count tablets per bottle (NDC 0143-1477-05), and c) 1000-count tablets per bottle (NDC 0143-1477-10), Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatowntown, NJ 07724.

Affected NDCs 0143-1477-01 0143-1477-05 0143-1477-10

Compare with the code on your package — it is the most precise check available.

Drug: Prednisone

Recalling firm
West-ward Pharmaceutical Corp.
NDC code
0143-1477-01
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-133-2013 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Prednisone recalls

See all
Class II · Moderate risk

PredniSONE Tablets

CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Terminated Temperature excursion Cardinal Healthcare D-0193-2024
Class II · Moderate risk

Prednisone Tablets

Labeling: Label Mix Up: bottle labeled to contain Prednisone Tablets, USP 2.5 mg actually contained Prednisone Tablets, USP 10 mg

Terminated Labeling / mix-up Lannett Company, Inc. NDC 0527-2931-37 D-1508-2020
Class II · Moderate risk

PredniSONE Tablets USP

Failed Tablet/Capsule Specifications: Discovery of an underweight tablet.

Terminated Failed specification West-Ward Pharmaceutical NDC 0054-4741-25 D-0008-2017
Class III · Low risk

Prednisone 20 mg

Labeling: Not elsewhere classified. NDC number is incorrect on the container.

Terminated Labeling / mix-up Northwind Pharmaceuticals LLC NDC 51655-320-53 D-0485-2016

Other recalls by West-ward Pharmaceutical Corp.

All 2012 recalls
Class II · Moderate risk

PredniSONE Tablets USP

Failed Tablet/Capsule Specifications: Discovery of an underweight tablet.

Terminated Failed specification West-Ward Pharmaceutical NDC 0054-4741-25 D-0008-2017
Class III · Low risk

Fentanyl Citrate Inj.

Failed Impurities/Degradation Specifications; 12 month stability testing (Expansion of RES #70548).

Terminated Impurity / degradation West-Ward Pharmaceutical Corp. NDC 0641-6028-25 D-1139-2015
Class III · Low risk

Fentanyl Citrate Inj.

Failed Impurities/Degradation Specifications; 12 month stability testing.

Terminated Impurity / degradation West-Ward Pharmaceutical Corporation NDC 0641-6028-25 D-0420-2015